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Clinical
Abstract
Introduction
Transient loss of consciousness (TLoC) affects up to half 
of the UK population at least once during their lifetime and 
commonly presents to physicians at all levels.1 We need 
to be able to recognise and manage the various causes 
of TLoC appropriately. Ictal asystole, defi ned as an R–R 
interval of >3–4 s,2 is a rarer cause of TLoC that is not 
well known amongst physicians. Therefore, although this 
is a treatable condition, the diagnosis is often delayed 
or missed, which may result in signifi cant harm.3 It is 
important to increase awareness and education around 
ictal asystole. 
Case presentation
Patient one was an otherwise healthy 57-year-old male 
with a history of sudden and intense episodes of déjà vu 
followed by TLoC. He would then make a rapid and complete 
recovery within seconds. There were no abnormal limb 
movements or tongue biting. The déjà vu was described 
as a brief (lasting seconds), stereotyped, intensely 
familiar feeling of detachment. There were six episodes 
over 2  years, each with no warning or provocation. He 
had a normal clinical examination, laboratory evaluation 
and brain MRI. Electroencephalography (EEG) was not 
performed. An initial diagnosis of vasovagal syncope was 
made in the cardiology clinic, following a normal 12-lead 
electrocardiogram and 24-hour Holter monitor, and he was 
discharged from follow up. However, as the symptoms 
persisted, the general practitioner referred him to neurology. 
An alternative diagnosis of focal epilepsy with ictal asystole 
was considered in the neurology clinic, given the prodrome 
of déjà vu symptoms. Levetiracetam was recommended 
and he was referred back to cardiology with a request for 
more prolonged monitoring. An implantable cardiac monitor 
was inserted. During a subsequent episode of déjà vu and 
TLoC, the implantable cardiac monitor captured marked 
sinus bradycardia at 10 beats per minute, progressing to 
periods of ventricular standstill. The patient underwent 
dual-chamber permanent pacemaker (PPM) insertion, 
which abolished TLoC. However, in the absence of TLoC, 
déjà vu became more frequent, intense and prolonged, 
at which point it became apparent that levetiracetam had 
not been commenced as originally suggested. The déjà vu 
resolved after this antiepileptic drug (AED) was prescribed 
and he remained seizure free for several months. He then 
experienced several secondary generalised tonic–clonic 
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seizures (GTCSs) and was switched to carbamazepine, on 
which he has continued to remain seizure free. 
Patient two was a 45-year-old female with type 1 diabetes. She 
presented to the fi rst seizure clinic following her fi rst GTCS. On 
questioning, she provided an 8-year history of episodes of déjà 
vu, describing dreamlike experiences that were brief (lasting 
seconds), stereotyped and intensely familiar. They occurred 
once every few months and usually resolved spontaneously. 
However, on some occasions, the déjà vu was followed by 
TLoC with rapid and complete recovery within seconds. On 
all occasions, her blood sugar was within normal limits. A 
clinical diagnosis of focal epilepsy was made and lamotrigine 
commenced. EEG and MRI head were normal. The history 
of TLoC and rapid recovery that followed some of her déjà 
vu episodes prompted a search for cardiac arrhythmias in 
association with the focal seizures. A 48-hour Holter monitor 
was arranged. This captured an episode of déjà vu and TLoC 
during which cardiac asystole was identifi ed as sinus arrest 
and ventricular standstill with a 13-s pause (Figure 1). She 
underwent dual-chamber PPM insertion and lamotrigine was 
stopped. She then re-presented with déjà vu followed by a 
GTCS despite a functioning PPM. Lamotrigine was restarted 
and she has since remained seizure free at 12 months.
Discussion
Diagnostic challenges
A rapid recovery following TLoC is usually consistent with a 
diagnosis of syncope,4,5 which was the presumed diagnosis 
for patient one initially. However, careful probing of the 
history revealed a stereotyped prodrome of brief déjà vu 
symptoms, and these should alert physicians that the 
patient is likely to be, instead, having focal seizures that 
are being complicated by ictal asystole. During the asystole, 
the patient loses consciousness as they would in syncope, 
hence the potential for diagnostic confusion. However, the 
underlying aetiology is epilepsy – which should not be missed 
and requires treatment. Indeed, despite levetiracetam and 
a functioning PPM, patient one went on to have GTCSs 
and required a change to carbamazepine. Patient two’s 
presentation with a déjà vu episodes and a GTCS seemed 
to indicate an uncomplicated diagnosis of focal epilepsy with 
secondary GTCSs. However, careful probing of the history 
revealed episodes of syncopal-sounding TLoC following the 
déjà vu events at times, and physicians should be aware that 
these raise the possibility that the patient is having their 
focal epilepsy complicated by ictal asystole. It is important 
to recognise this feature in the history as management may 
include not only AEDs, but also cardiology input for pacemaker 
consideration. In Box 1, we summarise the key features of a 
clinical history that may be suggestive of ictal asystole. Such 
patients warrant simultaneous referral to both neurology and 
cardiology with the query of ictal asystole specifi cally raised. 
Ictal asystole is a recognised complication of focal epilepsy, 
with a point prevalence of 0.32%.2 The origin of seizures 
is temporal in 90% of cases.2 When diagnosing temporal 
lobe epilepsy (TLE), interictal EEG showing focal epileptiform 
discharges may help further characterise seizures, but this 
investigation is normal in 71% of cases.6 Therefore, the 
diagnosis remains one that should be made on clinical 
grounds.6,7 More than 80% of patients with TLE describe 
an aura (focal seizure) with experiential and viscerosensory 
symptoms, such as the déjà vu described by our patients.6 
Such a history is often suffi cient to make a clinical diagnosis 
of focal epilepsy.6,8 
Ictal asystole presents as TLoC during a focal seizure. The 
asystole is a direct consequence of seizure activity simulating 
the central autonomic network.2,3 The mean duration of 
Figure 1 A three-lead Holter 
monitor trace demonstrating the 
onset of cardiac asystole during 
a stereotyped episode of intense 
déjà vu followed by transient loss 
of consciousness (TLoC) in 
patient two. This period of 
ventricular standstill carried on 
for 12.89 s before normal sinus 
rhythm resumed. BPM: beats per 
minute; HR: heart rate
Box 1 Red flag features in the clinical history that may be 
suggestive of ictal asystole
Red fl ags for when diagnosing syncope:
• A prodrome suggestive of seizures:
• Rising epigastric sensation
• Déjà vu or jamais vu
• Dreamlike state
• Abnormal taste/smell
• Episodes not previously appreciated as seizures, 
e.g. nocturnal events (waking up with tongue trauma, 
myalgia, confusion, lethargy)
• Risk factors for epilepsy (structural brain lesions, 
febrile convulsions, developmental/intellectual delay, 
family history of epilepsy) 
Red fl ags for when diagnosing seizures:
• Episodes are interrupted or followed by syncope, 
i.e. an abrupt loss of consciousness with rapid and 
spontaneous recovery (usually within minutes)
• Family history of a sudden unexplained death
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ventricular standstill is 20 s. During this, there is cerebral 
anoxia-ischemia and this results in termination of the seizure 
before it can progress further, and, therefore, termination of 
the asystole. In this manner, ictal asystole is normally self-
limiting. However, a minority continue into postictal asystole, 
which is fatal in 54% of cases.2 Postictal asystole is typically 
associated with secondary GTCSs and prolonged postictal 
apnoea that leads to cardiac arrest requiring resuscitation, 
and probably explains a proportion of sudden unexpected 
death in epilepsy (SUDEP).2 Ictal asystole has a variable 
expression and, therefore, does not occur during every 
seizure. Abolishing the asystole with a pacemaker removes 
the asystolic seizure self-termination mechanism, unmasking 
worsened seizures,3 as was seen in both of our patients after 
pacemaker insertion. 
Management challenges
The National Institute for Health and Care Excellence (NICE) 
recommends that patients presenting with TLoC and prodromal 
déjà vu or jamais vu should be referred for an epilepsy 
specialist review within 2 weeks.1 There are no guideline-
directed therapies for ictal asystole.9 This is likely owing to 
a lack of randomised trials. Whilst there is some literature 
suggesting that optimisation of AEDs alone may be effective in 
preventing ictal asystole, cardiac pacemakers help prevent the 
morbidity associated with falls secondary to asystole when a 
seizure does occur.9 This is important as only 60% of patients 
with newly diagnosed epilepsy achieve seizure freedom on 
their fi rst or second AED.10 In the seizure-free group, there 
is still a risk of seizure recurrence (and hence asystole) 
in the context of, for example, missed AEDs or vomiting. 
Therefore, as it is not possible to guarantee patients seizure 
freedom using AEDs, we argue that patients should not be 
exposed to the predictable risk of harm in relation to loss of 
consciousness or a fall from the ictal asystole. Furthermore, 
a causal role for ictal asystole in SUDEP,  although debated, 
is yet to be excluded.2,3,11 Cardiology guidelines recommend 
insertion of a PPM in symptomatic sinus bradycardia.4,12 There 
is no established minimum heart rate or pause duration at 
which PPM insertion is recommended; only the occurrence 
of symptoms is important.4,12 Therefore, notwithstanding the 
possibility of AEDs alone being suffi cient to prevent further 
seizures in some patients, once a patient has presented with 
the symptom of TLoC from ictal asystole, the management 
strategy seeming to most closely follow these guidelines would 
appear to be with PPM insertion. These issues should be 
discussed openly with patients in helping them come to a 
decision on their therapy. In our centre, we prefer a cautious 
management approach involving both AEDs and a PPM. 
Patients with ictal asystole are often seen by neurologists, 
cardiologists or both, but almost always separately. 
Information may go backwards and forwards between the two 
teams, but patients are at risk if that information sharing is 
incomplete. For one of our patients, that miscommunication 
resulted in a recommended AED never starting. For the other, 
it resulted in their AED being stopped. A joint cardiology and 
neurology clinic may be the best way forward to manage 
patients with ictal asystole. This may also assist in the 
management of some cardiac arrhythmias that can mimic 
epilepsy, such as long QT syndrome.13 In the absence of 
joint clinics, physicians need to communicate more closely 
about these patients. 
Conclusion
Careful attention should be paid to symptoms suggestive of 
focal seizures (e.g. déjà vu) in patients presenting with what 
otherwise sounds like syncope – they may have epilepsy 
presenting with ictal asystole. Equally important is paying 
careful attention to symptoms of syncope in what is otherwise 
sounds like a typical history of seizures – these patients 
may also have ictal asystole. Both AED treatment and 
cardiac investigations should be simultaneously arranged 
for patients suspected of ictal asystole. We encourage a 
cautious approach with AEDs and pacemaker insertion when 
managing patients with ictal asystole. The continuation of 
AEDs following pacemaker insertion is vital, as treating the 
cardiac arrhythmia may unmask seizures. Safe management 
of ictal asystole requires close communication between 
cardiology, neurology and admitting physicians. Any plans 
for commencing AEDs and inserting a pacemaker should be 
shared explicitly between teams. The patient’s perspective 
provided in Appendix A helps to contextualise these 
recommendations. 
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